On Thursday, MIRA Pharmaceuticals Inc. MIRA announced the formulation … ; Also Read: EXCLUSIVE: MIRA Pharmaceuticals Kick Starts Human Trial In Israel For Ketamir …

… drug implant company Nano Precision Medical merged with implantable visual prosthetics … proprietary neuromodulation technology and developing medical devices that address human conditions … company initiated a first-in-human trial for the long-lasting exenatide …

Treatment with the novel CTLA-4–targeted engineered toxin body MT-8421 was safe and produced no grade 4 or 5 toxicities in patients with select advanced solid tumors, according to findings from the dose-escalation portion of a first-in-human phase 1 trial …

Researchers at McMaster University have started a phase-2 clinical trial on a next-generation, inhaled COVID-19 vaccine. The AeroVax study, supported by $8M in funding from the Canadian Institutes of Health Research (CIHR), will test needle-free vaccines …

… Chinese medicine to promote health and healing. Chaga  … reduced inflammation and other health benefits. "This … health experts cite the lack of well-designed human trials examining … medications should consult their health care providers before drinking …

… therapies and improved global health outcomes grows exponentially. … technologies are changing the pharmaceutical industry by increasing … and early-stage human trials, saving time and … facilitating communication between pharmaceutical companies and regulatory …

… , causing a variety of health problems. The weakening of … push us beyond wearable health sensing. Please enable Javascript … tests and move ahead with human trials. The overarching goal is … ingestible capsule projects for health and wellness analysis. These …

… third startup, with Kitea Health hitting several milestones in … Unexpected data “Our first human trials have gone exceptionally well,” … the stage for US human trials beginning early next year. … &A that larger medical device manufacturers like Metronic …

… single-arm, first-in-human trial of PU-H71 in … should focus on its pharmacokinetic characteristics, optimal administration … to Panpan Huang), Gannan Medical University start-up funds … . Sesquiterpene lactones: adverse health effects and toxicity mechanisms. …

… time as CFO at Kiora Pharmaceuticals, securing more than $50 million … company previously eyed first-in-human trials midway through this year, but …